LEIDEN, NETHERLANDS--(MARKET WIRE)--Dec 8, 2008 --
Leiden, The Netherlands, December 8, 2008. Biotech company Pharming Group NV ("Pharming" or "the Company") (NYSE Euronext: PHARM) announced today that it has reached an agreement with several holders of convertible bonds to cancel outstanding debt by payments in cash and shares.
